drugset

drugset / Trial / NCT05493124

Clinical Study of Manpixiao in the Treatment of Chronic Atrophic Gastritis

NCT05493124 ↗

Phase 0 Unknown 180 enrolled Beijing University of Chinese Medicine

Non-randomizedParallel-groupOpen-labelTreatment

Summary

To explore the efficacy and safety of "Manpixiao" in the treatment of Chronic Atrophic Gastritis.

Timeline

Start: 2021-07-01
Primary completion: 2023-12-31
Completion: 2023-12-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Manpixiao	Unknown	17.15 g	—

Indications